期刊文献+

选择性绿激光治疗良性前列腺增生症患者 被引量:3

Green light photo selective vaporization of the prostate for the treatment of benign prostatic hyperplasia
下载PDF
导出
摘要 目的探讨应用选择性绿激光汽化术(PVP)治疗良性前列腺增生症(BPH)患者的临床疗效。方法应用PVP治疗56例BPH患者,观察其治疗效果。结果 56例手术均成功,术中、术后均无输血,平均手术时间为(60.4±6.6)min。平均留置尿管时间为(3.2±1.5)d,术后3个月国际前列腺症状评分(IPSS)评分、最大尿流率(Qmax)及前列腺体积改变均有统计学意义(P<0.05)。结论 PVP治疗BPH手术是一种安全可靠、出血少、并发症少、疗效确切的方法。 Objective To evaluate the efficacy of greenlight photoselective vaporization of the prostate(PVP) for the treatment of benign prostatic hyperplasia.Methods Application of PVP treatment of 56 patients with BPH,the treatment effect were observed.Results The PVP was successfully performed on all the 56 patients,none of them received blood transfusion and TUR syndrome.The operative time was(60.4±6.6) min and the postoperative urinary catheter time was(3.2±1.5) d.A significant improvement was observed in Qmax,IPSS values and prostate volume at 3 month(P〈0.01).Conclusion The PVP is safe and efficacious for BPH patients,with advantages of less blood loss,better tolerance and few complications.
出处 《中国医药导报》 CAS 2012年第10期188-189,共2页 China Medical Herald
关键词 绿激光 良性前列腺增生症 Green light Benign prostatic hyperplasia
  • 相关文献

参考文献2

二级参考文献31

  • 1陆菊丽.上海徐汇区部分老年人三年体检随访分析[J].老年医学与保健,1998,4(3):32-33. 被引量:2
  • 2洪宝发,蔡伟,符伟军,杨勇,王威,陈耀富,展洁,张翠娥,李炎唐,崔胜堂.选择性绿激光汽化术治疗良性前列腺增生的临床研究[J].中华泌尿外科杂志,2005,26(1):17-19. 被引量:90
  • 3顾方六,山岗志,王通生,薛兆英.北京城乡良性前列腺增生发病的差异[J].中华泌尿外科杂志,1995,16(7):387-390. 被引量:61
  • 4章大钧.区域性前列腺增生发病率调查[J].临床泌尿外科杂志,1995,10(6):364-365. 被引量:8
  • 5Uchida T,Ohori M,Soh S,et al.Factors influencing morbidity in patients undergoing transurethral resection of the prostate.Urology,1999 ,53:98-105.
  • 6Anson K.Could the latest generation potassium titanyl phosphate lasers be the ones to make transurethral resection of the prostate an operation of historical interest only? Curr Opin Urol,2004,14:27-29.
  • 7Shingleton WB,Terrell F,Renfroe L,et al.Low-power vs high-power KTP laser:improved method of laser ablation of prostate.J Endourol,1999,13:49-52.
  • 8Hai MA,Malek RS.Photoselective vaporization of the prostate :initial experience with a new 80 W KTP laser for the treatment of benign prostatic hyperplasia.J Endourol,2003 ,17 :93-96.
  • 9Reich O,Bachmann A,Schneede P,et al.Experimental comparison of high power (80 W) potassium titanyl phosphate laser vaporization and transurethral resection of the prostate.J Urol,2004,171 (6 Pt1) :2502-2504.
  • 10Malek RS,Kuntzman RS,Barrett DM.High power potassium-titanyl-phosphate laser vaporization prostatectomy.J Urol,2000,163:1730-1733.

共引文献150

同被引文献23

  • 1NICKEL JC, DOWNEY I, YOUNG I, et al. Asymptomatic in- flammation and/or infection in benign prostatic hyperplasia [ J ]. BJU Int, 1999, 84:976-981.
  • 2GERSTENBLUTH R E, STEI3'EL A D, MACLENNAN G T, et al. Distribution of chrinic prostatitis in radical prostatectomy spec- imens with up - regulation of Bcl - 2 in areas of inflammation[ J]. Urol, 2002, 167(5) :2267 -2270.
  • 3KRIEGER J N, RILEY D E, CHEAH P Y. Epidemiology of pros- tatitis : new evidence for a world - wide problem [ J ]. Urol, 2003, 21(2) :70-74.
  • 4GLEASON P E. Platelet derived growth factor(PDGF) ,androgens and inflammation: possible etiologic factors in the development of prostatic hyperplasia[ J ]. Urol, 1993, 149 (6) 1586 - 1592.
  • 5MARK A, PULLEN, KATHERINE THOMAS, et al. Stimulation of hyaluronan synthetase by platelet - derived growth factor bb in human prostate smooth muscle cells [ J]. Pharmacology, 2001, 62 : 103 - 106.
  • 6WANG W, BERGH A, DAMBER J E. Chronic inflammation in benign prostate hyperptasia is associated weth focal up regulation of cyclooxygenase - 2, Bcl - 2, and cell proliferation in the glandular epithelium[ J]. Prostate, 2004, 61:60 - 72.
  • 7SCHOBER A, BOTTNER M, STRELAU J, et al. Expression of growth differentiation factor - 15/macrophage inhibitory cytokine - 1 ( GDF - 15/MIC - 1 ) in the perinatal adult and injured rat brain [ J ]. Comp Neurol, 2001,439:32 - 45.
  • 8TAOKA R, TSUKUDA F, ISHIKAWA M, et al. Association ofprostatic inflammation with down - regulation of macrophage inhib- itory cytokine - 1 gene in symptomatic benign prostatic hyperplasia [J]. Urol, 2004, 171:2330-2335.
  • 9Rieken M,Bachmann A. Laser treatment of benign pros- tate enlargement-which laser for which prostate[J]. Nat Rev Uroi,2014,11(3) :142-152.
  • 10Vignozzi L, Rastrelli G,Corona G, et al. Benign prostatic hyperplasia:a new metabolic disease[J]. J Endocrinol In- vest, 2014,37 (4) : 313-322.

引证文献3

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部